₹ 130.33 Cr
2.61%
BSE Healthcare TRI
INF663L01Z52
5000.0
1000.0
1000
Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma, Puneet Pal
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| PGIM India Healthcare Fund - Regular Plan - Growth Option | 14.77 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
| Company | Holdings (%) |
|---|---|
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 10.36 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.25 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 8.49 |
| Clearing Corporation of India Ltd. | 5.24 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 4.96 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 4.71 |
| DR. LAL PATHLABS LIMITED EQ NEW FV RS. 10/- | 4.33 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 4.04 |
| Manipal Health Enterprises Ltd. A** | 3.68 |
| NAVIN FLUORINE INTERNATIONAL LTD EQ NEW FV RS. 2/- | 3.24 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 88.16 |
| Chemicals | 3.24 |
| Financial Services | 2.1 |
| Consumer Services | 0.99 |
| Information Technology | 0.4 |
| Scheme Name | 5Y (%) |
|---|---|
| PGIM India Healthcare Fund Reg Gr | 0.0 |